Alpha Teknova (TKNO) Amortization of Deferred Charges (2021 - 2026)

Alpha Teknova's (TKNO) quarterly Amortization of Deferred Charges came in at $47000.0 in Q1 2026, down 45.35% year-on-year from $86000.0 in Q1 2025, and little changed on a QoQ basis from $47000.0 in Q4 2025.

Alpha Teknova (TKNO) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends

Alpha Teknova (TKNO) has 6 years of Amortization of Deferred Charges data on file, last reported at $47000.0 in Q1 2026.

  • On a quarterly basis, Amortization of Deferred Charges fell 45.35% year-over-year to $47000.0 in Q1 2026; TTM through Mar 2026 was $181000.0, a 54.29% decrease from a year earlier, with the FY2025 full-year figure at $220000.0, down 44.16% from the prior year.
  • Amortization of Deferred Charges for Q1 2026 stood at $47000.0, roughly flat from $47000.0 in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for TKNO reached as high as $205000.0 in Q3 2023 and fell as low as $43000.0 in Q2 2025.
  • Historically, Amortization of Deferred Charges has averaged $84529.4 across 5 years, with a median of $84000.0 in 2024.
  • Across the five-year window, Amortization of Deferred Charges soared 241.67% in 2023 and tumbled 58.65% in 2025, its largest moves.
  • Year by year, Amortization of Deferred Charges stood at $119000.0 in 2022, then tumbled by 30.25% to $83000.0 in 2023, then advanced by 24.1% to $103000.0 in 2024, then tumbled by 54.37% to $47000.0 in 2025, then changed by 0.0% to $47000.0 in 2026.
  • Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $47000.0 in Q1 2026, $47000.0 in Q4 2025, and $44000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Alpha Teknova 278.75 Mn 260.97 Mn 3.78 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 47,000.00
Mar 31, 2026 47,000.00
Dec 31, 2025 47,000.00
Dec 31, 2025 47,000.00
Sep 30, 2025 44,000.00
Sep 30, 2025 44,000.00
Jun 30, 2025 43,000.00
Jun 30, 2025 43,000.00
Mar 31, 2025 86,000.00
Mar 31, 2025 86,000.00
Dec 31, 2024 103,000.00
Dec 31, 2024 103,000.00
Sep 30, 2024 103,000.00
Sep 30, 2024 103,000.00
Jun 30, 2024 104,000.00
Jun 30, 2024 104,000.00
Mar 31, 2024 84,000.00
Mar 31, 2024 84,000.00
Dec 31, 2023 83,000.00
Dec 31, 2023 83,000.00